Human bone marrow-derived endothelial cells (hBMECs) were used to study the impact of plasma proteins from patients with ALS and control subjects on endothelial cell (ECs) homeostasis and the immunoexpression of IL-6R and occludin (a tight junction protein) in endothelial cells. This evidence concerns the gene IL6R and amyotrophic lateral sclerosis.